BRPI0909770A2 - Vacina, e, kit - Google Patents

Vacina, e, kit

Info

Publication number: BRPI0909770A2
Authority: BR; Brazil
Prior art keywords: vaccine; kit
Prior art date: 2008-04-18

Application number

BRPI0909770-8A

Other languages

English (en)

Inventor

Antonius Arnoldus Christian Jacobs

Paul Vermeij

Ruud Philip Antoon Maria Segers

Carla Christina Schrier

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-18

Filing date

2009-04-16

Publication date

2015-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39496087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909770(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-16 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2015-08-11 Publication of BRPI0909770A2 publication Critical patent/BRPI0909770A2/pt

2021-09-28 Publication of BRPI0909770B1 publication Critical patent/BRPI0909770B1/pt

Links

229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BRPI0909770-8A 2008-04-18 2009-04-16 Vacina de antígenos não-vivos de lawsonia intracellularis, de mycoplasma hyopneumoniae e circovírus porcino BRPI0909770B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4618808P	2008-04-18	2008-04-18
US61/046,188		2008-04-18
EP08154765		2008-04-18
EP08154765.5		2008-04-18
PCT/EP2009/054517 WO2009127684A1 (en)	2008-04-18	2009-04-16	Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus

Publications (2)

Publication Number	Publication Date
BRPI0909770A2 true BRPI0909770A2 (pt)	2015-08-11
BRPI0909770B1 BRPI0909770B1 (pt)	2021-09-28

Family

ID=39496087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909770-8A BRPI0909770B1 (pt)	2008-04-18	2009-04-16	Vacina de antígenos não-vivos de lawsonia intracellularis, de mycoplasma hyopneumoniae e circovírus porcino

Country Status (13)

Country	Link
US (2)	US20110033497A1 (pt)
EP (2)	EP2633867B1 (pt)
JP (2)	JP6026107B2 (pt)
CN (2)	CN106729695A (pt)
BR (1)	BRPI0909770B1 (pt)
CA (1)	CA2718787C (pt)
DK (2)	DK2633867T3 (pt)
ES (2)	ES2666844T3 (pt)
HU (1)	HUE038425T2 (pt)
PL (2)	PL2291195T5 (pt)
RU (1)	RU2496520C2 (pt)
TW (1)	TWI449533B (pt)
WO (1)	WO2009127684A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
TWI551295B (zh)	2008-04-18	2016-10-01	英特威特國際股份有限公司	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2534556T3 (es) *	2008-07-22	2015-04-24	Intervet International Bv	Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
DK2569007T3 (en)	2010-05-11	2016-01-25	Intervet Int Bv	VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies
MX341622B (es)	2011-06-27	2016-08-25	Intervet Int Bv	Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico.
WO2013104550A1 (de) *	2012-01-13	2013-07-18	Boehringer Ingelheim Vetmedica Gmbh	Kit zur herstellung eines impfstoffs
US9474692B2 (en)	2012-01-13	2016-10-25	Boehringer Ingelheim Vetmedica Gmbh	Kit for the preparation of a vaccinating agent
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) *	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CN103031258B (zh) *	2012-06-29	2014-12-17	普莱柯生物工程股份有限公司	新的猪肺炎支原体菌株及其疫苗组合物
CN104450559B (zh) *	2012-06-29	2017-09-22	普莱柯生物工程股份有限公司	新的猪肺炎支原体菌株及其疫苗组合物
EP2684959A1 (en) *	2012-07-10	2014-01-15	Laboratorios Hipra, S.A.	Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
JP6484241B2 (ja) *	2013-12-03	2019-03-13	インターベットインターナショナルベー．フェー．	ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
CA2931137C (en) *	2013-12-03	2023-03-14	Intervet International B.V.	Vaccine against porcine circo virus type 2
EP3076995B1 (en)	2013-12-03	2020-03-11	Intervet International B.V.	Vaccine against lawsonia intracellularis and porcine circovirus 2
EP3253409B1 (en)	2015-02-04	2020-05-06	Intervet International B.V.	A vaccine for use against subclinical lawsonia infection in a pig
EP3253410B1 (en)	2015-02-04	2020-05-06	Intervet International B.V.	A vaccine for use against subclinical lawsonia infection in a pig
JP7558638B2 (ja) *	2016-03-23	2024-10-01	インターベットインターナショナルベー．フェー．	Ｐｃｖ２およびｐｒｒｓウイルス感染に対する皮内適用のためのワクチン
RU2018137034A (ru) *	2016-03-23	2020-04-23	Интервет Интернэшнл Б.В.	Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
JP6931059B2 (ja) *	2016-12-23	2021-09-01	インターベットインターナショナルベー．フェー．	豚用混合ワクチン
JP7665289B2 (ja) *	2017-04-13	2025-04-21	インターベットインターナショナルベー．フェー．	組合せ非混合使用のためのブタ病原体含有ワクチン
CL2017002196A1 (es) *	2017-08-30	2017-11-17	Univ De Concepción	Vacuna recombinante contra enteropatía proliferativa en animales.
MX2020005584A (es) *	2017-12-04	2020-09-14	Intervet Int Bv	Vacunacion con particulas de replicon y adyuvante oleoso.
US12290556B2 (en)	2017-12-18	2025-05-06	Intervet Inc.	Swine influenza a virus vaccine
US20230277649A1 (en)	2020-06-19	2023-09-07	Intervet Inc.	Swine influenza a virus vaccine comprising two distinct rna replicon particles
WO2021255225A1 (en)	2020-06-19	2021-12-23	Intervet International B.V.	Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
CN115836082A (zh)	2020-06-19	2023-03-21	英特维特国际股份有限公司	包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗
EP4168041A1 (en)	2020-06-19	2023-04-26	Intervet International B.V.	Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69015222T2 (de) *	1989-02-04	1995-05-04	Akzo Nv	Tocole als Impfstoffadjuvans.
US5714375A (en)	1995-06-05	1998-02-03	Nobl Laboratories, Inc.	Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
JP2000502054A (ja) *	1995-11-30	2000-02-22	アグリカルチャービクトリアサービシーズピーティーワイ．エルティーディー．	治療用および診断用の組成物
EP1324768A2 (en) *	2000-09-29	2003-07-09	The Arizona Board of Regents on Behalf of the University of Arizona	Vaccines for proliferative ileitis
DE60120621T2 (de) *	2000-12-20	2006-12-14	Intervet International B. V.	Lawsonia intracellularis Impfstoff
US7321065B2 (en) *	2003-04-18	2008-01-22	The Regents Of The University Of California	Thyronamine derivatives and analogs and methods of use thereof
TW200510524A (en) *	2003-07-25	2005-03-16	Boehringer Ingelheim Vetmed	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
UA87665C2 (ru)	2003-07-25	2009-08-10	Берингер Ингельхайм Ветмедика, Инк.	Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
BRPI0507017A (pt)	2004-01-22	2007-06-05	Intervet Int Bv	ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico
US20070212373A1 (en) *	2004-12-08	2007-09-13	Akzo Nobel N.V.	Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) *	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
DK1926496T3 (da)	2005-09-09	2013-09-30	Intervet Int Bv	PCV-2-vaccine
MX338626B (es)	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP2275132B1 (en)	2005-12-29	2021-03-03	Boehringer Ingelheim Animal Health USA Inc.	Multivalent PCV2 immunogenic compositions and methods of producing them
EP1991262A4 (en)	2006-03-03	2009-11-04	Merial Ltd	MYCOPLASMA HYOPNEUMONIAE VACCINE
WO2007116032A1 (en)	2006-04-10	2007-10-18	Intervet International B.V.	Vaccine against mycoplasma prrsv
WO2007138036A1 (en)	2006-05-30	2007-12-06	Intervet International B.V.	Vaccine against rickettsia-like organisms
JP5613061B2 (ja)	2008-01-23	2014-10-22	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法

2009
- 2009-03-30 TW TW098110513A patent/TWI449533B/zh active
- 2009-04-16 CN CN201611239977.4A patent/CN106729695A/zh active Pending
- 2009-04-16 JP JP2011504463A patent/JP6026107B2/ja active Active
- 2009-04-16 WO PCT/EP2009/054517 patent/WO2009127684A1/en not_active Ceased
- 2009-04-16 EP EP13169835.9A patent/EP2633867B1/en not_active Revoked
- 2009-04-16 EP EP09732113.7A patent/EP2291195B2/en active Active
- 2009-04-16 PL PL09732113T patent/PL2291195T5/pl unknown
- 2009-04-16 PL PL13169835T patent/PL2633867T3/pl unknown
- 2009-04-16 CA CA2718787A patent/CA2718787C/en active Active
- 2009-04-16 US US12/988,088 patent/US20110033497A1/en not_active Abandoned
- 2009-04-16 ES ES13169835.9T patent/ES2666844T3/es active Active
- 2009-04-16 BR BRPI0909770-8A patent/BRPI0909770B1/pt active IP Right Grant
- 2009-04-16 RU RU2010146950/15A patent/RU2496520C2/ru active
- 2009-04-16 CN CN200980112991XA patent/CN102006884A/zh active Pending
- 2009-04-16 ES ES09732113T patent/ES2534502T5/es active Active
- 2009-04-16 DK DK13169835.9T patent/DK2633867T3/en active
- 2009-04-16 HU HUE13169835A patent/HUE038425T2/hu unknown
- 2009-04-16 DK DK09732113.7T patent/DK2291195T4/da active
2013
- 2013-02-05 US US13/759,421 patent/US9084768B2/en active Active
2014
- 2014-09-05 JP JP2014180911A patent/JP6078504B2/ja active Active

Also Published As

Publication number	Publication date
CN102006884A (zh)	2011-04-06
ES2534502T5 (es)	2020-06-26
DK2291195T3 (en)	2015-05-11
JP6026107B2 (ja)	2016-11-16
PL2633867T3 (pl)	2018-07-31
RU2010146950A (ru)	2012-05-27
EP2633867B1 (en)	2018-03-21
EP2291195A1 (en)	2011-03-09
US20130183338A1 (en)	2013-07-18
TW201000123A (en)	2010-01-01
US20110033497A1 (en)	2011-02-10
EP2291195B1 (en)	2015-02-25
EP2291195B2 (en)	2019-11-13
EP2633867A1 (en)	2013-09-04
PL2291195T5 (pl)	2020-06-29
WO2009127684A1 (en)	2009-10-22
CA2718787C (en)	2018-04-10
ES2534502T3 (es)	2015-04-23
HUE038425T2 (hu)	2018-10-29
ES2666844T3 (es)	2018-05-08
CN106729695A (zh)	2017-05-31
TWI449533B (zh)	2014-08-21
RU2496520C2 (ru)	2013-10-27
PL2291195T3 (pl)	2015-07-31
US9084768B2 (en)	2015-07-21
CA2718787A1 (en)	2009-10-22
DK2291195T4 (da)	2020-02-10
DK2633867T3 (en)	2018-05-28
JP6078504B2 (ja)	2017-02-08
JP2011516601A (ja)	2011-05-26
JP2015028038A (ja)	2015-02-12
BRPI0909770B1 (pt)	2021-09-28

Legal Events

Date	Code	Title	Description
2017-09-05	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-10-09	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-11-10	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-08-10	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-09-28	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

Publication	Publication Date	Title
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
ATE450271T1 (de)	2009-12-15	Impfstoff
DK2114993T3 (da)	2012-10-22	Vaccine
DK2349430T3 (da)	2019-11-11	KATETERISERINGANORDNING og -kit
BR112012002349A2 (pt)	2015-10-13	composto,e, uso do mesmo
DE602009000234D1 (de)	2010-11-11	msignals
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
BRPI0917205A2 (pt)	2015-11-10	vacina polivalente
BRPI0914649A2 (pt)	2015-07-07	Piprazolo-quinazolinas
CR10571A (es)	2009-05-14	Vacuna virica recombinante
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DE602008003521D1 (de)	2010-12-30	Sitzrücklehnungsmechanismus
DK2300238T3 (da)	2013-12-16	Skyggebillede-sikkerhedstræk
DE602008003970D1 (de)	2011-01-27	Strahlstromkalibriersystem
BRPI0911625A2 (pt)	2015-08-04	Métodos
BRPI0907522A2 (pt)	2019-09-24	biarlamidas
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
BRPI0809678A2 (pt)	2014-10-07	Métodos
BRPI0909634A2 (pt)	2015-09-22	2-aminoquinolinas
DE112009001946A5 (de)	2011-07-14	Mobelauszugsführung
BRPI0907863A2 (pt)	2019-09-24	pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt)	2015-09-22	2-aminoquinolinas
BRPI0921578A2 (pt)	2019-09-24	vacinas unitemporais
AT507449A3 (de)	2010-11-15	Dämmstoffbefestiger
DE502008003019D1 (de)	2011-05-12	Einschraubverschraubung